Shi X - Search Results

1

Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer.

Guo S, Gao S, Liu R, Shen J, Shi X, Bai S, Wang H, Zheng K, Shao Z, Liang C, Peng S, Jin G. Guo S, et al. Among authors: shi x. FASEB J. 2019 Jan;33(1):873-884. doi: 10.1096/fj.201800617R. Epub 2018 Aug 9. FASEB J. 2019. PMID: 30091943

Pancreatic cancer (PC) samples <3 mm(3) were subcutaneously implanted into the NOD/Shi-scid/IL-2Rgammanull (NSG) mice. Once the xenograft reached 300-500 mm(3) or reached 180 d after cell inoculation, the tumor was excised. ...We concluded that tumor size and mutated VE …

Pancreatic cancer (PC) samples <3 mm(3) were subcutaneously implanted into the NOD/Shi-scid/IL-2Rgammanull (NSG) mice. Once the xe …

2

Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1).

Gao S, Zhu X, Shi X, Cao K, Bian Y, Jiang H, Wang K, Guo S, Zhang H, Jin G. Gao S, et al. Among authors: shi x. Radiat Oncol. 2019 Mar 27;14(1):52. doi: 10.1186/s13014-019-1254-8. Radiat Oncol. 2019. PMID: 30917842 Free PMC article. Clinical Trial.

3

Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients.

Guo S, Shi X, Shen J, Gao S, Wang H, Shen S, Pan Y, Li B, Xu X, Shao Z, Jin G. Guo S, et al. Among authors: shi x. Br J Cancer. 2020 Mar;122(6):857-867. doi: 10.1038/s41416-019-0704-2. Epub 2020 Jan 23. Br J Cancer. 2020. PMID: 31969677 Free PMC article.

4

A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.

Guo SW, Shen J, Gao JH, Shi XH, Gao SZ, Wang H, Li B, Yuan WL, Lin L, Jin G. Guo SW, et al. Surgery. 2020 Dec;168(6):1003-1014. doi: 10.1016/j.surg.2020.02.013. Epub 2020 Apr 19. Surgery. 2020. PMID: 32321665

5

Pros and Cons: High Proportion of Stromal Component Indicates Better Prognosis in Patients With Pancreatic Ductal Adenocarcinoma-A Research Based on the Evaluation of Whole-Mount Histological Slides.

Li B, Wang Y, Jiang H, Li B, Shi X, Gao S, Ni C, Zhang Z, Guo S, Xu J, Jin G. Li B, et al. Among authors: shi x. Front Oncol. 2020 Aug 21;10:1472. doi: 10.3389/fonc.2020.01472. eCollection 2020. Front Oncol. 2020. PMID: 32974173 Free PMC article.

6

Nomogram for the Prediction of High-Grade Dysplasia and Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas Based on Variables of Noninvasive Examination.

Li B, Shi X, Gao S, Shen S, Bian Y, Cao K, Pan Y, Zhang G, Jiang H, Li G, Guo S, Jin G. Li B, et al. Among authors: shi x. Front Oncol. 2021 Mar 9;11:609187. doi: 10.3389/fonc.2021.609187. eCollection 2021. Front Oncol. 2021. PMID: 33767983 Free PMC article.

7

Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma.

Li B, Shen S, You S, Zhang G, Gao S, Shi X, Wang H, Yin X, Xu X, Guo S, Jin G. Li B, et al. Among authors: shi x. BMC Cancer. 2021 May 26;21(1):612. doi: 10.1186/s12885-021-08380-9. BMC Cancer. 2021. PMID: 34034684 Free PMC article.

8

The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients.

Guo S, Shi X, Gao S, Hou Q, Jiang L, Li B, Shen J, Wang H, Shen S, Zhang G, Pan Y, Liu W, Xu X, Zheng K, Shao Z, Jing W, Lin L, Li G, Jin G. Guo S, et al. Among authors: shi x. Front Oncol. 2021 Jul 22;11:717989. doi: 10.3389/fonc.2021.717989. eCollection 2021. Front Oncol. 2021. PMID: 34368001 Free PMC article.

9

Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.

Guo S, Qin H, Liu K, Wang H, Bai S, Liu S, Shao Z, Zhang Y, Song B, Xu X, Shen J, Zeng P, Shi X, Chen H, Gao S, Xu J, Pan Y, Xiong L, Li F, Zhang D, Jiao X, Jin G. Guo S, et al. Among authors: shi x. Clin Transl Med. 2021 Sep;11(9):e520. doi: 10.1002/ctm2.520. Clin Transl Med. 2021. PMID: 34586739 Free PMC article.

10

Large-cohort humanized NPI mice reconstituted with CD34⁺ hematopoietic stem cells are feasible for evaluating preclinical cancer immunotherapy.

Xu X, Gu H, Li H, Gao S, Shi X, Shen J, Li B, Wang H, Zheng K, Shao Z, Cheng P, Cha Z, Peng S, Nie Y, Li Z, Guo S, Qian B, Jin G. Xu X, et al. Among authors: shi x. FASEB J. 2022 Apr;36(4):e22244. doi: 10.1096/fj.202101548RR. FASEB J. 2022. PMID: 35262964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,962 results

Search Page

Filters